Agents that act on the blood
Home > Preview
The flashcards below were created by user
on FreezingBlue Flashcards.
drugs that prolong the bodys ability to form a thrombus (clot) at different points in the coagulation cycle.
Intrinsic pathway and coagulation
Caused from peripheral vascular damage
coagulation inhibited by components entirely contained within the vasculature.
Goal of anticoagulant therapy
promote anticoagulation while minimizing hemorrhagic complications through careful monitoring.
no effect on existing clots- prevents formation of new thrombi
Binds with antithrombin III at two sites, first site has effect on factor x, and second site binding occurs at conversion of prothrombin to thrombin. TEST ???
Clotting factors have different half lives.
Which has shortest?
Factor VII - 6-9 hours
Factor II and X- up to 72 hours
What is gold standard for monitoring anticoagulant treatment
Dosage of warfarin
- long half life but narrow therapeutic window
- begin at 2.5- 5 mg daily
Range is 1-15 have to individualize dose
Acceptable INR in DVT
INR prevention of recurrent thrombosis
INR with cardiac valve replacement
- tissue valve 2.0-3.0
- Mechanical valve 2.5-3.5
INR recurrent systemic embolism
MOA of aspirin (platelet aggregator)
- inhibits cyclooxygenase in platelets and endothelial cells, preventing synthesis of thromboxane and prostacyclin.
- -both are potent platelet aggregators and vasoconstrictors.
Hold warfarin if INR is greater than
ASA is used prophylactically to
decrease incidence of MI/deaths in men > 50 years old. Treat unstable angina, non Q-wave infarction, and acute MI or CV
Monitoring of Warfarin
- Recommended dose 5-10 mg
- Decrease dose in elderly, usually in half
- Monitor INR every 2-3 days until goal is reached, then weekly, then every 2 weeks, then finally monthly when stable dose and stable INR
Warfarin pregnancy category
Most common problem in patients on aspirin taking NSAIDs is
Home > Flashcards > Print Preview